211 related articles for article (PubMed ID: 7636869)
1. Synthesis and biological evaluation of a series of substituted benzo[a]phenanthridines as agonists at D1 and D2 dopamine receptors.
Knoerzer TA; Watts VJ; Nichols DE; Mailman RB
J Med Chem; 1995 Aug; 38(16):3062-70. PubMed ID: 7636869
[TBL] [Abstract][Full Text] [Related]
2. trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine: a highly potent selective dopamine D1 full agonist.
Brewster WK; Nichols DE; Riggs RM; Mottola DM; Lovenberg TW; Lewis MH; Mailman RB
J Med Chem; 1990 Jun; 33(6):1756-64. PubMed ID: 1971308
[TBL] [Abstract][Full Text] [Related]
3. Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist.
Mottola DM; Brewster WK; Cook LL; Nichols DE; Mailman RB
J Pharmacol Exp Ther; 1992 Jul; 262(1):383-93. PubMed ID: 1352553
[TBL] [Abstract][Full Text] [Related]
4. 9-Dihydroxy-2,3,7,11b-tetrahydro-1H-naph[1,2,3-de]isoquinoline: a potent full dopamine D1 agonist containing a rigid-beta-phenyldopamine pharmacophore.
Ghosh D; Snyder SE; Watts VJ; Mailman RB; Nichols DE
J Med Chem; 1996 Jan; 39(2):549-55. PubMed ID: 8558526
[TBL] [Abstract][Full Text] [Related]
5. Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclase.
Mottola DM; Kilts JD; Lewis MM; Connery HS; Walker QD; Jones SR; Booth RG; Hyslop DK; Piercey M; Wightman RM; Lawler CP; Nichols DE; Mailman RB
J Pharmacol Exp Ther; 2002 Jun; 301(3):1166-78. PubMed ID: 12023552
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and pharmacological evaluation of substituted naphth[1,2,3-de]isoquinolines (dinapsoline analogues) as D1 and D2 dopamine receptor ligands.
Qandil AM; Lewis MM; Jassen A; Leonard SK; Mailman RB; Nichols DE
Bioorg Med Chem; 2003 Apr; 11(7):1451-64. PubMed ID: 12628671
[TBL] [Abstract][Full Text] [Related]
7. Dopaminergic benzo[a]phenanthridines: resolution and pharmacological evaluation of the enantiomers of dihydrexidine, the full efficacy D1 dopamine receptor agonist.
Knoerzer TA; Nichols DE; Brewster WK; Watts VJ; Mottola D; Mailman RB
J Med Chem; 1994 Jul; 37(15):2453-60. PubMed ID: 7914538
[TBL] [Abstract][Full Text] [Related]
8. Locomotor inhibition, yawning and vacuous chewing induced by a novel dopamine D2 post-synaptic receptor agonist.
Smith HP; Nichols DE; Mailman RB; Lawler CP
Eur J Pharmacol; 1997 Mar; 323(1):27-36. PubMed ID: 9105873
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of cis- and trans-9- and 11-hydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridines as structurally rigid, selective D1 dopamine receptor ligands.
Brewster WK; Nichols DE; Watts VJ; Riggs RM; Mottola D; Mailman RB
J Med Chem; 1995 Jan; 38(2):318-27. PubMed ID: 7830274
[TBL] [Abstract][Full Text] [Related]
10. Multiple dopamine receptors mediate the discriminative stimulus effects of dihydrexidine in rats.
Gleason SD; Yin T; Little SP; Delapp N; Witkin JM
Behav Pharmacol; 2011 Sep; 22(5-6):531-9. PubMed ID: 21836463
[TBL] [Abstract][Full Text] [Related]
11. Effects of dopamine D1 receptor agonists in rats trained to discriminate dihydrexidine.
Gleason SD; Witkin JM
Psychopharmacology (Berl); 2006 May; 186(1):25-31. PubMed ID: 16575553
[TBL] [Abstract][Full Text] [Related]
12. trans-hexahydroindolo[4,3-ab]phenanthridines ("benzergolines"), the first structural class of potent and selective dopamine D1 receptor agonists lacking a catechol group.
Seiler MP; Hagenbach A; Wüthrich HJ; Markstein R
J Med Chem; 1991 Jan; 34(1):303-7. PubMed ID: 1671417
[TBL] [Abstract][Full Text] [Related]
13. Effects of dopamine D1 receptor full agonists in rats trained to discriminate SKF 38393.
Gleason SD; Witkin JM
Behav Pharmacol; 2004 Feb; 15(1):85-9. PubMed ID: 15075630
[TBL] [Abstract][Full Text] [Related]
14. Further definition of the D1 dopamine receptor pharmacophore: synthesis of trans-6,6a,7,8,9,13b-hexahydro-5H-benzo[d]naphth[2,1-b]azepines as rigid analogues of beta-phenyldopamine.
Negash K; Nichols DE; Watts VJ; Mailman RB
J Med Chem; 1997 Jul; 40(14):2140-7. PubMed ID: 9216832
[TBL] [Abstract][Full Text] [Related]
15. trans-2,3-dihydroxy-6a,7,8,12b-tetrahydro-6H-chromeno[3,4-c]isoquinoline: synthesis, resolution, and preliminary pharmacological characterization of a new dopamine D1 receptor full agonist.
Cueva JP; Giorgioni G; Grubbs RA; Chemel BR; Watts VJ; Nichols DE
J Med Chem; 2006 Nov; 49(23):6848-57. PubMed ID: 17154515
[TBL] [Abstract][Full Text] [Related]
16. Hexahydrobenzo[a]phenanthridines: novel dopamine D3 receptor ligands.
Watts VJ; Lawler CP; Knoerzer T; Mayleben MA; Neve KA; Nichols DE; Mailman RB
Eur J Pharmacol; 1993 Aug; 239(1-3):271-3. PubMed ID: 8223910
[TBL] [Abstract][Full Text] [Related]
17. Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.
Collins GT; Witkin JM; Newman AH; Svensson KA; Grundt P; Cao J; Woods JH
J Pharmacol Exp Ther; 2005 Jul; 314(1):310-9. PubMed ID: 15833897
[TBL] [Abstract][Full Text] [Related]
18. Analogues of doxanthrine reveal differences between the dopamine D1 receptor binding properties of chromanoisoquinolines and hexahydrobenzo[a]phenanthridines.
Cueva JP; Chemel BR; Juncosa JI; Lill MA; Watts VJ; Nichols DE
Eur J Med Chem; 2012 Feb; 48():97-107. PubMed ID: 22204903
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and molecular modeling of 1-phenyl-1,2,3,4-tetrahydroisoquinolines and related 5,6,8,9-tetrahydro-13bH-dibenzo[a,h]quinolizines as D1 dopamine antagonists.
Minor DL; Wyrick SD; Charifson PS; Watts VJ; Nichols DE; Mailman RB
J Med Chem; 1994 Dec; 37(25):4317-28. PubMed ID: 7996543
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and dopamine receptor affinities of N-alkyl-11-hydroxy-2-methoxynoraporphines: N-alkyl substituents determine D1 versus D2 receptor selectivity.
Si YG; Gardner MP; Tarazi FI; Baldessarini RJ; Neumeyer JL
J Med Chem; 2008 Feb; 51(4):983-7. PubMed ID: 18251489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]